AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Cefpodoxime (Cefpodoxime Proxetil) in Nigeria
28 products registered with NAFDAC — 28 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Mospodox 50 mg/5 mLSuspension_ Suspension | A11-0860 | Miraflash Nig Ltd | active | 25 Nov 2030 |
| Cefdoxim 200 Tablets_ Tablet | A4-8923 | Digitall Healthcare Ltd | active | 25 Nov 2030 |
| Mospodox 100 mg/5 mL Suspension_ Suspension | A11-0875 | Miraflash Nig Ltd | active | 28 Oct 2030 |
| Jandox-200 Tablet** Tablet | A4-100950 | Onifam Laboratories Limited | active | 30 Jul 2029 |
| Mospodox 200 mg Capsule_ Capsule | A11-0859 | Miraflash Nig Ltd | active | 26 Jun 2029 |
| Kadcep (check dosage form) Tablet | A11-100552 | Kadark Pharmaceuticals Limited | active | 26 Jul 2028 |
| Mplon-200 Tablet** Tablet | A4-4972 | Feccox Pharmacy and General Enterprises Ltd | active | 25 Apr 2028 |
| Podexil Powder for Oral Suspension Powder for suspension | B4-7808 | Standard Generics Limited | active | 25 Apr 2028 |
| Tambac 200 Tablets Tablet | B4-6174 | Interpharma Industries Limited | active | 15 Dec 2026 |
| Tambac 100 Tablet Tablet | B4-6175 | Interpharma Industries Limited | active | 15 Dec 2026 |
| Cfpoxime 50 Tablet | B4-2239 | Chanrai HealthCare Limited | active | 1 Dec 2026 |
| Cefdoxim Powder Suspension | B4-6622 | Digitall Healthcare Ltd | active | 1 Dec 2026 |
| Cfpoxime 200 Tablet | B4-2238 | Chanrai HealthCare Limited | active | 1 Dec 2026 |
| Orelox 100 mg Tablets Tablet | A4-2816 | Sanofi-Aventis Nigeria Limited | active | 27 Oct 2026 |
| Everdestiny Cefpodoxime 200 Tablets Tablet | C4-1894 | Everdestiny Pharmaceutical Ltd | active | 27 Oct 2026 |
| Tambact-50 Powder for Oral Suspension Powder for suspension | A4-0281 | Interpharma Industries Limited | active | 27 Oct 2026 |
| Everdestiny Cefpodoxime 100 Tablets# Tablet | C4-1895 | Everdestiny Pharmaceutical Ltd | active | 27 Oct 2026 |
| Cefadox-200 Tablets** Tablet | A4-6502 | Micro Nova Pharmaceuticals Ind Ltd | active | 25 Aug 2026 |
| Cefadox 100 Tablets** Tablet | A4-6426 | Micro Nova Pharmaceuticals Ind Ltd | active | 26 May 2026 |
| Kalcep 200 Tablets Tablet | C4-1659 | Pushkal Pharmaceutical Limited | active | 28 Mar 2026 |
| Kalcep 100 Tablets Tablet | C4-1658 | Pushkal Pharmaceutical Limited | active | 28 Mar 2026 |
| Cefpodoxime Proxetil Sandoz Tablet** Tablet | C4-1626 | Novartis Nigeria Limited | active | 24 Feb 2026 |
| Tipkin 200 Capsules Capsule | C4-1604 | Dony-Triumph and Company Nigeria Limited | active | 24 Feb 2026 |
| Orelox 200 mg Tablets Tablet | B4-2087 | Sanofi-Aventis Nigeria Limited | active | 27 Jan 2026 |
| Cefpodoxime Proxetil USP 200 mg Tablets Tablet | C4-1522 | BG Pharma & Healthcare Limited | active | 20 Dec 2025 |
| Orelox Granules for Oral Suspension Granules for suspension | A4-2723 | Sanofi-Aventis Nigeria Limited | active | 20 Dec 2025 |
| Kamalox 200 Tablet Tablet | B4-4577 | De-VisionPharma Co. Limited | active | 20 Dec 2025 |
| Cesart-200 Tablets Tablet | B4-2620 | Astranad Pharmaceuticals and Chemical Company Limited | active | 9 Nov 2025 |
Cefpodoxime (Cefpodoxime Proxetil) — NAFDAC Registration Details
NAFDAC (Nigeria) has 28 registered products containing Cefpodoxime (Cefpodoxime Proxetil), of which 28 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Cefpodoxime (Cefpodoxime Proxetil) registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.